Regenosine
Jersey City, United States (US) · Health and Medical
Do your work at Regenosine?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Regenosine is a US-based pharmaceutical company pioneering the path to tissue regeneration, specializing in the development of first-in-class regenerative therapies for osteoarthritis and other indications.We harness the healing potential of adenosine, utilizing a proprietary liposomal adenosine intraarticular injection to address the underlying mechanisms of osteoarthritis.
Overview
We harness the healing potential of adenosine, utilizing a proprietary liposomal adenosine intraarticular injection to address the underlying mechanisms of osteoarthritis. Our technology offers a disease-modifying approach, aiming to halt disease progression and promote cartilage regeneration, rather than simply managing symptoms.
Regenosine’s breakthrough therapy delivers a slow-release adenosine formulation, providing up to 15 days of sustained therapeutic effect within the joint. Independent third-party validation confirms significant long-term pain relief, enhanced functional recovery, and reduced radiological and histological signs of osteoarthritis progression. We are committed to improving clinical outcomes and patient quality of life, and reducing the total healthcare delivery costs associated with regenerative medicine.
Contact Details
Jersey City, United States (US)
Founded
2018
Company Type
Private Limited Company
Employees
2-10
Categories
Companies teams usually look at after Regenosine
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.